Ditchcarbon
  • Contact
  1. Organizations
  2. Virbac group
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 6 days ago

Virbac group Sustainability Profile

Company website

Virbac Group, a leading player in the global animal health industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1964, the company has established itself as a trusted provider of veterinary products and services, focusing on the health and well-being of companion animals and livestock. Virbac's core offerings include vaccines, pharmaceuticals, and nutritional products, all designed to enhance animal health and productivity. What sets Virbac apart is its commitment to research and development, ensuring innovative solutions tailored to the evolving needs of veterinarians and pet owners alike. With a strong market position, Virbac has achieved notable milestones, including a robust international presence and a diverse product portfolio that reflects its dedication to quality and efficacy in animal care.

DitchCarbon Score

How does Virbac group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

31

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Virbac group's score of 31 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Let us know if this data was useful to you

Virbac group's reported carbon emissions

In 2022, Virbac Group reported total carbon emissions of approximately 23,727,000 kg CO2e, all of which fall under Scope 1 emissions. This marks an increase from 20,814,000 kg CO2e in 2021 and 21,007,000 kg CO2e in 2020. The company has not disclosed any Scope 2 or Scope 3 emissions data for these years. Virbac's emissions data from 2014 indicates a more comprehensive reporting approach, with total emissions of 15,014,000 kg CO2e from Scope 2 and 6,818,000 kg CO2e from Scope 3, alongside 19,186,000 kg CO2e from Scope 1. This earlier data highlights the company's broader emissions profile, including significant contributions from purchased goods and services. Despite the lack of specific reduction targets or commitments, Virbac is actively engaged in climate initiatives, as evidenced by their participation in the CDP. However, no specific science-based targets (SBTi) or documented reduction initiatives have been reported. Overall, while Virbac has shown a commitment to transparency in emissions reporting, the absence of reduction targets suggests an opportunity for further climate action and commitment to sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2014202020212022
Scope 1
19,186,000
00,000,000
00,000,000
00,000,000
Scope 2
15,014,000
-
-
-
Scope 3
6,818,000
-
-
-

How Carbon Intensive is Virbac group's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Virbac group's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Virbac group's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Virbac group is in FR, which has a very low grid carbon intensity relative to other regions.

Virbac group's Scope 3 Categories Breakdown

Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 17% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the primary emissions source at 73% of Scope 3 emissions.

Top Scope 3 Categories

2014
Purchased Goods and Services
73%

Virbac group's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Virbac group has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Virbac group's Emissions with Industry Peers

MSD Animal Health

GB
•
Chemicals nec
Updated 2 months ago

Alk

DK
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Heska Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Idexx Laboratories

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Huvepharma EOOD

BG
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Vetoquinol SA

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy